Search

Search Results

• 

  Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

  S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

  368-373

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.368

  2534

  PDF: 909
• 

  Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)

  G. Lapadula, A. Marchesoni, F. Salaffi, R. Ramonda, C. Salvarani, L. Punzi, L. Costa, F. Caso, D. Simone, G. Baiocchi, C. Scioscia, M. Di Carlo, R. Scarpa, G. Ferraccioli

  126-136

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.913

  3391

  PDF: 2259
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  5113

  PDF: 3300
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2654

  PDF: 1688
• 

  Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

  A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli

  5-10

  https://doi.org/10.4081/reumatismo.2011.5

  2575

  PDF: 1928

• Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative”

  F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini

  34-45

  https://doi.org/10.4081/reumatismo.2010.34

  2325

  PDF: 2402

• Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE

  P. Tomietto, V. Annese, S. D’Agostini, E. Gremese, E. Di Poi, G. Ferraccioli

  171-180

  https://doi.org/10.4081/reumatismo.2003.171

  1759

  PDF: 1592

• Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis

  S. Alivernini, A.L. Fedele, I. Cuoghi, B. Tolusso, G. Ferraccioli

  85-94

  https://doi.org/10.4081/reumatismo.2008.85

  1604

  PDF: 1261

• Leptin: regulatory role in bone metabolism and in flogosis

  G. De Marchi, G.D. Ferraccioli

  217-225

  https://doi.org/10.4081/reumatismo.2002.217

  1402

  PDF: 3944

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  https://doi.org/10.4081/reumatismo.2006.50

  1018

  PDF: 2193

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  https://doi.org/10.4081/reumatismo.2002.19

  1411

  PDF: 832

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  870

  PDF: 743

• Neurological involvement in systemic sclerosis. Evidence of a central Raynaud’s phenomenon

  E. Di Poi, M. Bombardieri, R. Damato, E. Gremese, G. Valesini, GF. Ferraccioli

  289-297

  https://doi.org/10.4081/reumatismo.2001.289

  1054

  PDF: 841

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  816

  PDF: 766

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  https://doi.org/10.4081/reumatismo.2004.143

  1632

  PDF: 1145

• Mycophenolic acid in Rheumatology: mechanisms of action and severe adverse events

  G. Zizzo, M. De Santis, G.F. Ferraccioli

  91-100

  https://doi.org/10.4081/reumatismo.2010.91

  1670

  PDF: 1487

• Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

  M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli

  94-103

  https://doi.org/10.4081/reumatismo.2004.94

  1541

  PDF: 1001